Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Dianthus Therapeutics, Inc.(DNTH) | 3,204,184 | 2,104,184 | -1,100,000 | $126.08M | $86.71M | 25.01% | -$39.37M |
| CG Oncology, Inc.(CGON) | 1,600,899 | 1,472,699 | -128,200 | $64.48M | $61.15M | 17.64% | -$3.34M |
| Jade Biosciences Inc | 1,127,186 | 1,400,708 | +273,522 | $9.73M | $21.61M | 6.23% | +$11.89M |
| Oruka Therapeutics, Inc.(ORKA) | 660,424 | 660,424 | 0 | $12.70M | $20.02M | 5.77% | +$7.32M |
| Teva Pharmaceutical Industries LimitedADS(TEVA) | 510,000 | 417,300 | -92,700 | $10.30M | $13.02M | 3.76% | +$2.72M |
| Boston Scientific Corporation(BSX) | 164,300 | 114,500 | -49,800 | $16.04M | $10.92M | 3.15% | -$5.12M |
| Medtronic plcSHS(MDT) | 190,600 | 107,600 | -83,000 | $18.15M | $10.34M | 2.98% | -$7.82M |
| Perspective Therapeutics, Inc.(CATX) | 2,994,033 | 3,210,733 | +216,700 | $10.27M | $8.83M | 2.55% | -$1.44M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 0 | 21,000 | +21,000 | $0 | $8.35M | 2.41% | +$8.35M |
| Repligen Corporation(RGEN) | 23,300 | 50,300 | +27,000 | $3.11M | $8.24M | 2.38% | +$5.13M |
| Context Therapeutics Inc.(CNTX) | 8,981,855 | 5,504,855 | -3,477,000 | $8.70M | $8.09M | 2.33% | -$609.5K |
| McKesson Corporation(MCK) | 5,800 | 9,520 | +3,720 | $4.48M | $7.81M | 2.25% | +$3.33M |
| ICON Public Limited CompanySHS(ICLR) | 0 | 33,100 | +33,100 | $0 | $6.03M | 1.74% | +$6.03M |
| Agilent Technologies, Inc.(A) | 0 | 41,500 | +41,500 | $0 | $5.65M | 1.63% | +$5.65M |
| Pfizer Inc.(PFE) | 366,400 | 203,600 | -162,800 | $9.34M | $5.07M | 1.46% | -$4.27M |
| Centene Corporation(CNC) | 0 | 119,400 | +119,400 | $0 | $4.91M | 1.42% | +$4.91M |
| Kenvue Inc.(KVUE) | 265,200 | 232,800 | -32,400 | $4.30M | $4.02M | 1.16% | -$288.4K |
| Danaher Corporation(DHR) | 54,700 | 17,000 | -37,700 | $10.84M | $3.89M | 1.12% | -$6.95M |
| Thermo Fisher Scientific Inc.(TMO) | 18,900 | 6,700 | -12,200 | $9.17M | $3.88M | 1.12% | -$5.28M |
| Novo Nordisk A/SADR(NVO) | 0 | 67,300 | +67,300 | $0 | $3.42M | 0.99% | +$3.42M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 306,000 | 206,076 | -99,924 | $3.60M | $3.42M | 0.99% | -$182.8K |
| Encompass Health Corporation(EHC) | 41,900 | 31,600 | -10,300 | $5.32M | $3.35M | 0.97% | -$1.97M |
| The Cigna Group(CI) | 16,600 | 11,600 | -5,000 | $4.78M | $3.19M | 0.92% | -$1.59M |
| Cencora Inc | 19,000 | 9,400 | -9,600 | $5.94M | $3.17M | 0.92% | -$2.76M |
| Insmed Incorporated(INSM) | 11,600 | 17,700 | +6,100 | $1.67M | $3.08M | 0.89% | +$1.41M |
| Waters Corporation(WAT) | 0 | 8,100 | +8,100 | $0 | $3.08M | 0.89% | +$3.08M |
| Acadia Pharmaceuticals Inc | 144,000 | 106,900 | -37,100 | $3.07M | $2.86M | 0.82% | -$217.7K |
| Genmab A/SADS(GMAB) | 248,100 | 92,000 | -156,100 | $7.61M | $2.83M | 0.82% | -$4.78M |
| Natera, Inc.(NTRA) | 70,400 | 11,800 | -58,600 | $11.33M | $2.70M | 0.78% | -$8.63M |
| Immunic, Inc.(IMUX) | 4,699,411 | 4,699,411 | 0 | $4.14M | $2.51M | 0.72% | -$1.63M |
| Acadia Healthcare Company, Inc.(ACHC) | 0 | 169,000 | +169,000 | $0 | $2.40M | 0.69% | +$2.40M |
| Integer Holdings Corporation(ITGR) | 0 | 29,800 | +29,800 | $0 | $2.34M | 0.67% | +$2.34M |
| Enliven Therapeutics Inc | 140,300 | 140,300 | 0 | $2.87M | $2.16M | 0.62% | -$711.3K |
| Palvella Therapeutics, Inc.(PVLA) | 0 | 19,300 | +19,300 | $0 | $2.02M | 0.58% | +$2.02M |
| HealthEquity, Inc.(HQY) | 25,300 | 16,900 | -8,400 | $2.40M | $1.55M | 0.45% | -$849.5K |
| SCYNEXIS, Inc.(SCYX) | 3,350,528 | 2,081,660 | -1,268,868 | $2.58M | $1.32M | 0.38% | -$1.26M |
| IQVIA Holdings Inc.(IQV) | 0 | 4,400 | +4,400 | $0 | $991.8K | 0.29% | +$991.8K |
| Karyopharm Therapeutics Inc.(KPTI) | 134,566 | 134,566 | 0 | $880.1K | $990.4K | 0.29% | +$110.3K |
| Corcept Therapeutics Incorporated(CORT) | 0 | 22,000 | +22,000 | $0 | $765.6K | 0.22% | +$765.6K |
| AbbVie Inc.(ABBV) | 19,800 | 0 | -19,800 | $4.58M | $0 | — | -$4.58M |
| Akero Therapeutics Inc | 40,500 | 0 | -40,500 | $1.92M | $0 | — | -$1.92M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 214,400 | 0 | -214,400 | $4.04M | $0 | — | -$4.04M |
| Arvinas, Inc.(ARVN) | 698,363 | 0 | -698,363 | $5.95M | $0 | — | -$5.95M |
| Ascendis Pharma A/SADR(ASND) | 14,500 | 0 | -14,500 | $2.88M | $0 | — | -$2.88M |
| Beam Therapeutics Inc.(BEAM) | 112,000 | 0 | -112,000 | $2.72M | $0 | — | -$2.72M |
| Bristol-Myers Squibb Company(BMY) | 257,600 | 0 | -257,600 | $11.62M | $0 | — | -$11.62M |
| Carlsmed, Inc.(CARL) | 321,912 | 0 | -321,912 | $4.31M | $0 | — | -$4.31M |
| Endeavour Silver Corp.(EXK) | 73,600 | 0 | -73,600 | $4.03M | $0 | — | -$4.03M |
| Immuneering CorpCL A | 90,900 | 0 | -90,900 | $636.3K | $0 | — | -$636.3K |
| Johnson & Johnson(JNJ) | 26,800 | 0 | -26,800 | $4.97M | $0 | — | -$4.97M |
| Metsera Inc | 140,500 | 0 | -140,500 | $7.35M | $0 | — | -$7.35M |
| UnitedHealth Group Incorporated(UNH) | 17,800 | 0 | -17,800 | $6.15M | $0 | — | -$6.15M |
| Wave Life Sciences, Inc.SHS(WVE) | 297,500 | 0 | -297,500 | $2.18M | $0 | — | -$2.18M |
| Xenon Pharmaceuticals Inc.(XENE) | 53,400 | 0 | -53,400 | $2.14M | $0 | — | -$2.14M |